Status: current, Primitive. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4945778012 | Molnupiravir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4945779016 | Molnupiravir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Molnupiravir | Is a | Pyrimidine nucleoside | true | Inferred relationship | Some | ||
| Molnupiravir | Is a | Hydroxylamine | true | Inferred relationship | Some | ||
| Molnupiravir | Is a | Antiviral | true | Inferred relationship | Some | ||
| Molnupiravir | Is a | Ribonucleoside | true | Inferred relationship | Some | ||
| Molnupiravir | Has disposition | Antiviral | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Molnupiravir 200 mg oral capsule | Has precise active ingredient | True | Molnupiravir | Inferred relationship | Some | 1 |
| Molnupiravir 200 mg oral capsule | Has BoSS | True | Molnupiravir | Inferred relationship | Some | 1 |
| Molnupiravir-containing product | Has active ingredient | True | Molnupiravir | Inferred relationship | Some | 1 |
| Molnupiravir only product | Has active ingredient | True | Molnupiravir | Inferred relationship | Some | 1 |
| Molnupiravir-containing product in oral dose form | Has active ingredient | True | Molnupiravir | Inferred relationship | Some | 1 |
| Molnupiravir only product in oral dose form | Has active ingredient | True | Molnupiravir | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR